Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer.
The purpose of this study is to compare the proportions of participants in the tomosynthesis mammography (TM) and digital mammography (DM) study arms experiencing the occurrence of an advanced breast cancer at any time during a period of 4.5 years from randomization, including the period of active screening and a period of clinical follow-up after the last screen (T4).
Participants will not be paid for their participation.
- IRB Number: 1708650574 (RADY-ECOG-WESTPHAL-EA1151)
- Research Study Identifier: TX8481
- Principal Investigator: Steven Westphal, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required